It's no secret that doctors are helping many people lose weight by prescribing GLP-1 medications like Ozempic, Wegovy, ...

Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from several medical societies, including the American Society of ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...

Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...

Smoothie King says it is the first quick service restaurant brand with a GLP-1 focused menu.

The 12-week human clinical trial began in early June 2024 and set out to investigate if, through these mechanisms of action, ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

When food enters the digestive system, specialized cells in the small intestine release GLP-1, initiating a cascade of ...

A large retrospective study, the first of its kind, reported reduced rates of EO-CRC in patients younger than 50 years of age ...

Smoothie King's new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 medications." ...